[MOL] Re: Breast Cancer Abstracts.... [01815] Medicine On Line


[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] Re: Breast Cancer Abstracts....







>
> CHAKRAVARTY PK, Sinha DK.
> Pregnancy induced mammary tumor specific effector cells are present long
> after parturition in a breast cancer model in rats.
> Cancer Lett 2000;154:1-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10799733&aid=B120232&dopt=r&s=bc
>
> IMYANITOV EN, Togo AV, Suspitsin EN, et al.
> Evidence for microsatellite instability in bilateral breast carcinomas.
> Cancer Lett 2000;154:9-17.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10799734&aid=B120232&dopt=r&s=bc
>
> UCHIDA M, Tsuboi H, Yamaji T, et al.
> Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against
mammary
> carcinoma induced by dimethylbenz[a]anthracene in
> rats and angiogenesis in the rabbit cornea - comparison with
medroxyprogesterone
> acetate (MPA).
> Cancer Lett 2000;154:63-9.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10799740&aid=B120232&dopt=r&s=bc
>
> NASIR L, Krasner H, Argyle DJ, Williams A.
> Immunocytochemical analysis of the tumour suppressor protein (p53) in
feline
> neoplasia.
> Cancer Lett 2000;155:1-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10814873&aid=B120232&dopt=r&s=bc
>
> BADRIA F, Mabed M, Khafagy W, Abou-Zeid L.
> Potential utility of antineoplaston A-10 levels in breast cancer.
> Cancer Lett 2000;155:67-70.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10814881&aid=B120232&dopt=r&s=bc
>
> HIROSE M, Yamaguchi T, Lin C, et al.
> Effects of arctiin on PhIP-induced mammary, colon and pancreatic
carcinogenesis
> in female Sprague-Dawley rats and MeIQx-induced
> hepatocarcinogenesis in male F344 rats.
> Cancer Lett 2000;155:79-88.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10814883&aid=B120232&dopt=r&s=bc
>
> TAKEI H, Lee ES, Cisneros A, Jordan VC.
> Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7
> breast tumors in nude mice.
> Cancer Lett 2000;155:129-35.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10822127&aid=B120232&dopt=r&s=bc
>
> GRADISHAR WJ, Soff G, Liu J, et al.
> A pilot trial of suramin in metastatic breast cancer to assess
antiangiogenic
> activity in individual patients.
> Oncology 2000;58:324-33.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10838499&aid=B120232&dopt=r&s=bc
>
> KLIJN JG, Beex LV, Mauriac L, et al.
> Combined treatment with buserelin and tamoxifen in premenopausal
metastatic
> breast cancer: a randomized study.
> J Natl Cancer Inst 2000;92:903-11.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10841825&aid=B120232&dopt=r&s=bc
>
> PATNAIK A, MacKinnon J, Goss P, et al.
> Phase I/II trial of cyclophosphamide, mitoxantrone, and escalated doses
> of carboplatin supported by peripheral-blood stem cells in
> women with metastatic breast cancer.
> J Clin Oncol 2000;18:2363-8.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856095&aid=B120232&dopt=r&s=bc
>
> SPARANO JA, O'Neill A, Schaefer PL, Falkson CI, Wood WC.
> Phase II trial of doxorubicin and docetaxel plus granulocyte colony-
stimulating
> factor in metastatic breast cancer: Eastern
> Cooperative Oncology Group Study E1196.
> J Clin Oncol 2000;18:2369-77.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856096&aid=B120232&dopt=r&s=bc
>
> SMITH IE, Johnston SR, O'Brien ME, et al.
> Low-dose oral fluorouracil with eniluracil as first-line chemotherapy
against
> advanced breast cancer: a phase II study.
> J Clin Oncol 2000;18:2378-84.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856097&aid=B120232&dopt=r&s=bc
>
> NORRIS B, Pritchard KI, James K, et al.
> Phase III comparative study of vinorelbine combined with doxorubicin
versus
> doxorubicin alone in disseminated metastatic/recurrent
> breast cancer: National Cancer Institute of Canada Clinical Trials Group
> Study MA8.
> J Clin Oncol 2000;18:2385-94.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856098&aid=B120232&dopt=r&s=bc
>
> GEELS P, Eisenhauer E, Bezjak A, Zee B, Day A.
> Palliative effect of chemotherapy: objective tumor response is associated
> with symptom improvement in patients with metastatic
> breast cancer.
> J Clin Oncol 2000;18:2395-405.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856099&aid=B120232&dopt=r&s=bc
>
> OBEDIAN E, Fischer DB, Haffty BG.
> Second malignancies after treatment of early-stage breast cancer:
lumpectomy
> and radiation therapy versus mastectomy.
> J Clin Oncol 2000;18:2406-12.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856100&aid=B120232&dopt=r&s=bc
>
> MATLOFF ET, Shappell H, Brierley K, Bernhardt BA, McKinnon W, Peshkin BN.
> What would you do? Specialists' perspectives on cancer genetic testing,
> prophylactic surgery, and insurance discrimination.
> J Clin Oncol 2000;18:2484-92.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10856109&aid=B120232&dopt=r&s=bc
>
> SCOTT AM, Geleick D, Rubira M, et al.
> Construction, production, and characterization of humanized anti-Lewis Y
> monoclonal antibody 3S193 for targeted immunotherapy of
> solid tumors.
> Cancer Res 2000;60:3254-61.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866319&aid=B120232&dopt=r&s=bc
>
> LIN F, Xiao D, Kolluri SK, Zhang X.
> Unique anti-activator protein-1 activity of retinoic acid receptor beta.
> Cancer Res 2000;60:3271-80.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866321&aid=B120232&dopt=r&s=bc
>
> SINGH R, Pervin S, Karimi A, Cederbaum S, Chaudhuri G.
> Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-
> arginine selectively inhibits cell proliferation and
> induces apoptosis in MDA-MB-468 cells.
> Cancer Res 2000;60:3305-12.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10866325&aid=B120232&dopt=r&s=bc
>
> COCCONI G, Mambrini A, Quarta M, et al.
> Vinorelbine combined with paclitaxel infused over 96 hours (VI-TA-96) for
> patients with metastatic breast carcinoma.
> Cancer 2000;88:2731-8.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870055&aid=B120232&dopt=r&s=bc
>
> HERON DE, Komarnicky LT, Hyslop T, Schwartz GF, Mansfield CM.
> Bilateral breast carcinoma: risk factors and outcomes for patients with
> synchronous and metachronous disease.
> Cancer 2000;88:2739-50.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870056&aid=B120232&dopt=r&s=bc
>
> KUMAR NB, Cantor A, Allen K, Cox CE.
> Android obesity at diagnosis and breast carcinoma survival: Evaluation of
> the effects of anthropometric variables at diagnosis,
> including body composition and body fat distribution and weight gain
during
> life span,and survival from breast carcinoma.
> Cancer 2000;88:2751-7.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870057&aid=B120232&dopt=r&s=bc
>
> PEDRAZZOLI P, Lanza A, Battaglia M, et al.
> Negative immunomagnetic purging of peripheral blood stem cell harvests
from
> breast carcinoma patients reduces tumor cell
> contamination while not affecting hematopoietic recovery.
> Cancer 2000;88:2758-65.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10870058&aid=B120232&dopt=r&s=bc
>
> KIM SH, Forman AP, Mathews MB, Gunnery S.
> Human breast cancer cells contain elevated levels and activity of the
protein
> kinase, PKR.
> Oncogene 2000;19:3086-94.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10871861&aid=B120232&dopt=r&s=bc
>
> ZHANG HT, Scott PA, Morbidelli L, et al.
> The 121 amino acid isoform of vascular endothelial growth factor is more
> strongly tumorigenic than other splice variants in vivo.
> Br J Cancer 2000;83:63-8.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10883669&aid=B120232&dopt=r&s=bc
>
> SASO R, Kulkarni S, Mitchell P, et al.
> Secondary myelodysplastic syndrome/acute myeloid leukaemia following
mitoxantrone-based
> therapy for breast carcinoma.
> Br J Cancer 2000;83:91-4.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10883674&aid=B120232&dopt=r&s=bc
>
> CAMERON DA, Gregory WM, Bowman A, et al.
> Identification of long-term survivors in primary breast cancer by dynamic
> modelling of tumour response.
> Br J Cancer 2000;83:98-103.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10883676&aid=B120232&dopt=r&s=bc
>
> SHARPE CR, Collet JP, McNutt M, Belzile E, Boivin JF, Hanley JA.
> Nested case-control study of the effects of non-steroidal anti-
inflammatory
> drugs on breast cancer risk and stage.
> Br J Cancer 2000;83:112-20.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10883678&aid=B120232&dopt=r&s=bc
>
> SALA E, Warren R, Duffy S, Welch A, Luben R, Day N.
> High risk mammographic parenchymal patterns and diet: a case-control
study.
> Br J Cancer 2000;83:121-6.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10883679&aid=B120232&dopt=r&s=bc
>
> MEIJERS-HEIJBOER EJ, Verhoog LC, Brekelmans CT, et al.
> Presymptomatic DNA testing and prophylactic surgery in families with a
BRCA1
> or BRCA2 mutation.
> Lancet 2000;355:2015-20.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10885351&aid=B120232&dopt=r&s=bc
>
> UENO T, Toi M, Koike M, Nakamura S, Tominaga T.
> Tissue factor expression in breast cancer tissues: its correlation with
> prognosis and plasma concentration.
> Br J Cancer 2000;83:164-70.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10901365&aid=B120232&dopt=r&s=bc
>
> MARTIN AM, Weber BL.
> Genetic and Hormonal Risk Factors in Breast Cancer.
> J Natl Cancer Inst 2000;92:1126-1135.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10904085&aid=B120232&dopt=r&s=bc
>
> KIRSCHMANN DA, Lininger RA, Gardner LM, et al.
> Down-regulation of HP1Hsalpha expression is associated with the metastatic
> phenotype in breast cancer.
> Cancer Res 2000;60:3359-63.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910038&aid=B120232&dopt=r&s=bc
>
> BEMIS LT, Schedin P.
> Reproductive state of rat mammary gland stroma modulates human breast
cancer
> cell migration and invasion.
> Cancer Res 2000;60:3414-8.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910049&aid=B120232&dopt=r&s=bc
>
> VOLK EL, Rohde K, Rhee M, et al.
> Methotrexate cross-resistance in a mitoxantrone-selected multidrug-
resistant
> MCF7 breast cancer cell line is attributable to
> enhanced energy-dependent drug efflux.
> Cancer Res 2000;60:3514-21.
>
> Abstract:
http://www.amedeo.com/lit.cfm?uid=A10910063&aid=B120232&dopt=r&s=bc


------------------------------------------------------------------------
This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------